Back to Search
ERNESTO RIVERA, MD
MD
Pediatric Cardiology Physician
NPI: 1689695447IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Cardiology PhysicianPrimary
Pediatrics — Pediatric Cardiology
Code: 2080P0202X
036-107892(IL)C52608(CA)
Education
OTHER
Class of 1987
Research & Publications (20)
Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
PMID 19675449·Am J Clin Oncol·2010
6-review
Implementation of different initiatives to develop a culture of professionalism in the medical school.
PMID 19530555·P R Health Sci J·2009
8-other
A comparison of experimental aneurysm occlusion determination by angiography, scanning electron microscopy, MICROFIL perfusion, and histology.
PMID 19582862·J Biomed Mater Res B Appl Biomater·2009
4-observational
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.
PMID 18300256·Cancer·2008
3-trial
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
PMID 16909414·Cancer·2006
3-trial
Ethyl alcohol production optimization by coupling genetic algorithm and multilayer perceptron neural network.
PMID 16915705·Appl Biochem Biotechnol·2006
8-other
Trends in recommendations of myelosuppressive chemotherapy for the treatment of breast cancer: evolution of the national comprehensive cancer network guidelines and the cooperative group studies.
PMID 16764742·Clin Breast Cancer·2006
4-observational
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
PMID 16340083·J Alzheimers Dis·2005
8-other
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
PMID 15041710·Clin Cancer Res·2004
3-trial
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.
PMID 12947059·J Clin Oncol·2003
3-trial
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study.
PMID 12927041·Breast Cancer Res·2003
4-observational
Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.
PMID 12872339·Cancer·2003
4-observational
Current status of liposomal anthracycline therapy in metastatic breast cancer.
PMID 14667278·Clin Breast Cancer·2003
6-review
Liposomal anthracyclines in metastatic breast cancer: clinical update.
PMID 13679590·Oncologist·2003
6-review
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
PMID 11914909·Cancer Chemother Pharmacol·2002
8-other
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
PMID 12015755·Cancer·2002
3-trial
Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
PMID 11844821·J Clin Oncol·2002
3-trial
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
PMID 11251001·J Clin Oncol·2001
3-trial
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
PMID 11147589·Cancer·2000
3-trial
Study of kinetic parameters in a mechanistic model for bioethanol production through a screening technique and optimization.
PMID 19125302·Bioprocess Biosyst Eng·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1600 EUREKA RD
ROSEVILLE, CA 95661 - Phone
- (916) 784-4000
Quick Facts
- NPI
- 1689695447
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile